Raffaella M. Schmid

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617

Christoph A. Umbricht, Martina Benešová, Raffaella M. Schmid et al. · EJNMMI Research · 2017 · 196 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization

Klaudia Siwowska, Raffaella M. Schmid, Susan Cohrs et al. · Pharmaceuticals · 2017 · 87 citations · Full text

Medicine, Oncology, Pharmacology +9

44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations

Katharina A. Domnanich, Cristina Müller, Renáta Farkas et al. · EJNMMI Radiopharmacy and Chemistry · 2016 · 78 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imaging

Cristina Müller, Christiaan Vermeulen, K. Johnston et al. · EJNMMI Research · 2016 · 60 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Synthesis, Radiolabeling, and Characterization of Plasma Protein-Binding Ligands: Potential Tools for Modulation of the Pharmacokinetic Properties of (Radio)Pharmaceuticals

Cristina Müller, Renáta Farkas, Francesca Borgna et al. · Bioconjugate Chemistry · 2017 · 44 citations

Medicine, Pharmaceutics, Pharmacology +17